Haldar, US
Amlan Haldar, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20140025493 | CUSTOM RETARGETING DESCRIPTION LANGUAGE - A system and method for re-targeting users includes: logging user activity within a network of users; categorizing parameters of the user activity; storing the categorized parameters; receiving a request for re-targeting; reformulating the request using a custom language definition; and running the re-formulated request against the stored categorized parameters to generate a list of users matching the request. | 01-23-2014 |
Amrita Haldar, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20100313944 | WRAPPED OPTOELECTRONIC DEVICES AND METHODS FOR MAKING SAME - In various embodiments, optoelectronic devices are described herein. The optoelectronic device may include an optoelectronic cell arranged so as to wrap around a central axis wherein the cell includes a first conductive layer, a semi-conductive layer disposed over and in electrical communication with the first conductive layer, and a second conductive layer disposed over and in electrical communication with the semi-conductive layer. In various embodiments, methods for making optoelectronic devices are described herein. The methods may include forming an optoelectronic cell while flat and wrapping the optoelectronic cell around a central axis. The optoelectronic devices may be photovoltaic devices. Alternatively, the optoelectronic devices may be organic light emitting diodes. | 12-16-2010 |
20110146755 | VERTICALLY STACKED PHOTOVOLTAIC AND THERMAL SOLAR CELL - According to some embodiments, the present invention provides a novel photovoltaic solar cell system from photovoltaic modules that are vertically arrayed in a stack format using thin film semiconductors selected from among organic and inorganic thin film semiconductors. The stack cells may be cells that are produced in a planar manner, then vertically oriented in an angular form, also termed herein tilted, to maximize the light capturing aspects. The use of a stack configuration system as described herein allows for the use of a variety of electrode materials, such as transparent materials or semitransparent metals. Light concentration can be achieved by using fresnel lens, parabolic mirrors or derivatives of such structures. The light capturing can be controlled by being reflected back and forth in the photovoltaic system until significant quantities of the resonant light is absorbed. Light that passes to the very end and can be reflected back through the device by beveling or capping the end of the device with a different refractive index material, or alternatively using a reflective surface. The contacting between stacked cells can be done in series or parallel. According to some embodiments, the present invention uses a concentrator architecture where the light is channeled into the cells that contain thermal fluid channels (using a transparent fluid such as water) to absorb and hence reduce the thermal energy generation. | 06-23-2011 |
20140342098 | Waterproof Coating with Nanoscopic/Microscopic Features and Methods of Making Same - A process of fabricating the waterproof coating may include selecting a substrate, utilizing a sol-gel comprising a silane or silane derivative and metal oxide precursor to coat the substrate, and optionally coating the substrate with a hydrophobic chemical agent and/or other chemical agents to create a surface with nanoscopic or microscopic features. The process may utilize an all solution process or controlled environment for fabricating self-cleaning and waterproof coating that prevent wetting or staining of a substrate, or may utilize a controlled environment. | 11-20-2014 |
20150064340 | FIXED AND PORTABLE COATING APPARATUSES AND METHODS - A system and method for depositing a coating may comprise a coating chemical reactor, surface activation component, and a deposition component. A target surface may be prepared for deposition with the surface activation component. The coating chemical reactor may comprise a coating chemical dispenser and a coating chemical verifier that prepares the coating chemical for deposition. The coating chemical verifier may utilize an optical excitation source and at least one optical detector, wherein chemical substances are identified by unique signatures composed of binary code. The coating chemical may be received by the deposition component to depositing the coating chemical on the target surface. | 03-05-2015 |
Debashis Haldar, Olathe, KS US
Patent application number | Description | Published |
---|---|---|
20100050255 | DETECTION AND SUPPRESSION OF SHORT MESSAGE SERVICE DENIAL OF SERVICE ATTACKS - A method, system, and medium are provided for suppressing a Short Message Service (SMS) induced Denial of Service (DoS) attack on a telecommunications network. A register is updated to include information relevant to SMS messages that are requested to be communicated by way of a wireless telecommunications network. The register includes information of the location where the target devices of SMS messages are located. The register is utilized to detect an SMS induced DoS attack. A trigger is communicated to an SMS router to enable a DoS mode that restricts the communication of SMS messages. In an exemplary embodiment, only those SMS messages identified as part of the DoS attack are restricted. | 02-25-2010 |
20120212439 | Customized Grouping of Participants in Real-Time Conference Set-Up - A customized list of real-time conference participants are obtained by selecting one or more logical operators such as AND or OR and applying the one or more logical operators to conference groups the user has selected. The logical operators and selected conference groups are sent to a conference server, which applies the operator to the selected groups to arrive at a shortlist of conference participants. The invention is particularly useful for cellular telephones initiating a real-time conference using the Session Initiation Protocol (SIP) and a SIP server resident on a network. | 08-23-2012 |
20140018074 | NOTIFYING A WIRELESS COMMUNICATION SYSTEM ABOUT PREVIOUSLY REGISTERED WIRELESS COMMUNICATION SYSTEMS - Embodiments disclosed herein provide systems and methods that notify a current wireless communication network about a previous wireless communication network. In a particular embodiment, a wireless device wirelessly registers with a first wireless communication system to obtain first registration data. The wireless device stores the first registration data and wirelessly communicates over the first wireless communication system. The communications are then terminated with the first wireless communication system. After terminating the wireless communications with the first wireless communication system, the wireless device wirelessly registers with a second wireless communication system to obtain second registration data and stores the second registration data. The wireless device transfers the first registration data to the second wireless communication system and receives user information from the second wireless communication system. The second wireless communication system used the first registration data to retrieve the user information from the first wireless communication system. | 01-16-2014 |
Jayanta Haldar, South Boston, MA US
Patent application number | Description | Published |
---|---|---|
20090081249 | Bi-Functional Polymer-Attached Inhibitors of Influenza Virus - Antimicrobial compositions containing two or more antiviral agents coupled to a polymer and methods of making and using the compositions, are described herein. In one embodiment, two or more antiviral agents are covalently coupled to the polymer. Suitable antiviral agents include, but are not limited to, sialic acid, zanamivir, oseltamivir, amantadine, rimantadine, and combinations thereof. The polymer is preferably a water-soluble, biocompatible polymer. Suitable polymers include, but are not limited to, poly(isobutylene-alt-maleic anhydride) (PIBMA), poly(aspartic acid), poly(l-glutamic acid), polylysine, poly(acrylic acid), plyaginic acid, chitosan, carboxymethyl cellulose, carboxymethyl dextran, polyethyleneimine, and blends and copolymers thereof. In another embodiment, the compositions contain a physical mixture of polymer containing one antiviral agent and polymer containing a second antiviral agent. The compositions can be formulated for enteral or parenteral administration. Suitable oral/intranasal dosage forms include, but are not limited to, tablets, capsules, solutions, suspensions, emulsions, syrups, and lozenges. Suitable dosage forms for parenteral administration include, but are not limited to, solutions, suspensions, and emulsions. The compositions described herein are effective at treating a variety of infections, including viral infections such as influenza, while inhibiting or preventing the development of microbial resistance. | 03-26-2009 |
Jayanta Haldar, Belmont, MA US
Patent application number | Description | Published |
---|---|---|
20100136072 | Polymeric Coatings that Inactivate Viruses and Bacteria - Hydrophobic polymeric coatings which can be non-covalently applied to solid surfaces such as metals, plastics, glass, polymers, textiles, and other substrates such as fabrics, gauze, bandages, tissues, and other fibers, in the same manner as paint, for example, by brushing, spraying, or dipping, to make the surfaces virucidal and bactericidal, have been developed. | 06-03-2010 |
Justin P. Haldar, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20140210474 | LINEAR TRANSFORM FOR DIFFUSION MRI - Samples of a Fourier transform of a signal may be received that are distributed in a generally spherically-shaped pattern on a surface of at least one sphere. The samples may be assembled to form a profile function having a domain that is a surface of at least one sphere. Information indicative of at least one property of the signal may be determined by applying a spherical linear transform to the profile function. The spherical linear transform may use more than just an equator of the profile function for each of multiple orientations. | 07-31-2014 |
Kasturi Haldar, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20130273086 | Compositions And Methods For Treatment, Research And Therapeutic Applications For Malaria - The present invention provides anti- | 10-17-2013 |
20150359762 | COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CEREBRAL INJURY - Methods and compositions which include or include the administration of a hydrophobic drug, prodrug thereof, salt thereof, isoform thereof, or a combination thereof; cyclodextrin, prodrug thereof, salt thereof, or a combination thereof; polyethylene glycol, propylene glycol, or combination thereof; and optionally, a pharmaceutically acceptable carrier. | 12-17-2015 |
Kasturi Haldar, South Bend, IN US
Patent application number | Description | Published |
---|---|---|
20090136529 | Compositions And Methods For Treatment, Research And Therapeutic Applications For Malaria - The present invention provides anti- | 05-28-2009 |
Malay Haldar, Salt Lake City, UT US
Patent application number | Description | Published |
---|---|---|
20110061116 | Animal Model of Synovial Sarcoma - Synovial sarcoma is an aggressive soft-tissue malignancy. Disclosed herein is an animal model of synovial sarcoma wherein one or more myogenic cells of the animal express recombinant SYT-SSX fusion polypeptide. Using this model, myoblasts were identified as a source of synovial sarcoma. Remarkably, within the skeletal muscle lineage, while expression of the oncoprotein in immature myoblasts leads to induction of synovial sarcoma with 100% penetrance, its expression in more differentiated cells induces myopathy without tumor induction. In addition, early widespread expression of the disclosed fusion protein disrupts normal embryogenesis, causing lethality. | 03-10-2011 |
Malay Haldar, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20140282260 | GENERATING AN IMAGE STREAM - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for augmenting an interactive session with images. In one aspect, a method includes generating a first linear arrangement of images captured during an interactive session. The images of the first linear arrangement of images can be arranged in order based on a sequence in which the images were captured. The first linear arrangement of images is provided for display. Selection data specifying a selection of an image of the first linear arrangement of images are received. In response to receiving the selection data, a branch point is created at the selected image. The branch point can define a branch from the selected image to a second linear arrangement of images. Additional images captured during the interactive session are received. The second linear arrangement of images is generated that includes the additional images. | 09-18-2014 |
Manas K. Haldar, Fargo, ND US
Patent application number | Description | Published |
---|---|---|
20100221344 | Functionalized Nanoceria Composition For Ophthalmic Treatment - The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma. | 09-02-2010 |
20110268662 | FUNCTIONALIZED NANOCERIA COMPOSITION FOR OPHTHALMIC TREATMENT - The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma. | 11-03-2011 |
20130123515 | FUNCTIONALIZED NANOCERIA COMPOSITION FOR OPHTHALMIC TREATMENT - The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma. | 05-16-2013 |
20150241456 | METHODS FOR USING LIPID PARTICLES - Provided herein are methods for using lipid particles. In one embodiment, lipid particles are used for determining whether a composition includes a charged contaminant. The method includes combining a test composition that includes an analyte with lipid particles to form a mixture, and determining whether there is any change in zeta potential of the mixture and/or average aggregate diameter of liposome aggregates in the mixture. In one embodiment, lipid particles are used for enriching an analyte. The method includes combining a test composition that includes an analyte with lipid particles and multivalent cations to form a mixture, incubating the mixture under conditions suitable for forming a complex that includes the analyte bound to the lipid particle, and separating the complex from the contaminant present in the mixture. | 08-27-2015 |
20160000724 | CONTROLLED RELEASE NANOPARTICLES AND METHODS OF USE - Provided herein are nanoparticles that include a lipid layer and a compartment surrounded by the lipid layer. The lipid layer may include a lipid and a lipoprotein. The lipid may include a POPE lipid covalently attached to a hydrophilic polymer by a disulfide bond. The lipoprotein may include a trigger protein. The concentration of the first lipid may be between 1 mol % and 30 mol %. The disulfide bond of the first lipid is stable under conditions that include 10% human serum and is broken under conditions that include 50 micromolar glutathione. The hydrophilic polymer may include a PEG molecule. The trigger protein may include an amino acid repeat region, such as (GPX)n. The trigger protein may include a peptide bond that is cleaved by a gelatinase (e.g., gelatinase-B protease), or a member of the ADAM family of proteases (e.g., ADAM10 protease). Also provided are methods of using the nanoparticles. | 01-07-2016 |
Rama Haldar, Randolph, NJ US
Patent application number | Description | Published |
---|---|---|
20100104656 | Meltable Binder for Melt Granulation and/or Pelletization - A low melting binder composition for preparation of pharmaceutical tablets and/or granules which comprises a polymer and a hydrophobic meltable binder. | 04-29-2010 |
Rama Krishna Haldar, Randolph, NJ US
Patent application number | Description | Published |
---|---|---|
20120178822 | Co-Processed Excipient Compositions - An oral solid dosage form having improved dissolution profile and a method of producing the same are provided. The present invention particularly provides a co-processed excipient composition and a method of producing the same. More particularly, it relates to a co-processed binary mixture of crosslinked polyvinylpyrrolidone and calcium silicate; wherein the weight ratio of crosslinked polyvinylpyrrolidone and calcium silicate is in the range of 1:1 to 20:1. The binary mixture when combined with a poorly soluble drug enhances its dissolution and extent of release. | 07-12-2012 |
Saptarsi M. Haldar, Pepper Pike, OH US
Patent application number | Description | Published |
---|---|---|
20160095867 | BET INHIBITION THERAPY FOR HEART DISEASE - Method for treating cardiac diseases using BET inhibitors including JQ1 are provided. Methods for treating cardiac hypertrophy, method for treating heart failure not arising from inflammation, methods for treating myocardial infarction, methods for cardioprotection and methods for inhibiting restenosis are described herein. The methods involve the use of effective amounts of BET inhibitors such as JQ1. | 04-07-2016 |
Tathagata Haldar, Pottstown, PA US
Patent application number | Description | Published |
---|---|---|
20090037242 | System for Monitoring Periodic Processing of Business Related Data - A system stores and analyzes task processing statistical data and adaptively calculates the overall completion time of day-end processing of a set of standard jobs that create reports that need to be run at the end of each business day, for example, to extract and summarize key business data. In response different processing loads and task execution times occurring on different days. A system for monitoring periodic processing of business related data to provide reports at day end and other times, includes a repository of information. The information identifies multiple measured time durations required for processing business related data to provide a corresponding plurality of reports for individual days of multiple days. A computation processor determines an average time duration for processing business related data to provide an individual report by averaging measured time durations required for processing data to provide the individual report over multiple days. The computation processor uses the average time duration, together with a reference time of processing, to provide a predicted time of completion of processing to provide the individual report. A communication processor provides result data to a user. The result data represents the predicted time of completion of processing to provide the individual report. | 02-05-2009 |